• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX HEMOCONCENTRATOR; DIALYZER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX HEMOCONCENTRATOR; DIALYZER Back to Search Results
Catalog Number CX-XR270M024
Device Problem Complete Blockage (1094)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/09/2017
Event Type  malfunction  
Manufacturer Narrative
The actual device was returned to the manufacturing facility for evaluation.Visual inspection found no anomalies in the appearance.There was no formation of clots inside the device.The actual sample, after having been rinsed, was subjected to another visual inspection.No break or plugging in the fiber was confirmed.The actual sample was built into a circuit with tubes, where bovine blood flowed directly.Blood was confirmed to run through the device.There was no difficulty with the filtrate pathway being filled with filtrate.Bovine blood was circulated in the circuit at the flow rate of 500ml/minute and tmp 400mmhg.During the circulation, the pressure loss was determined.The obtained values were confirmed to meet manufacturing specifications.Subsequently, the ultrafiltration performance was determined and verified to meet manufacturing specifications.A review of the device history record and product release decision control sheet of the involved product code/lot # combination was conducted with no relevant findings.A search of the complaint file found no other report with the involved product code/lot# combination.There is no evidence that this event was related to a device defect or malfunction.The inspection results verified the actual device was the normal product.While the exact cause of the reported event cannot be definitively determined based on the available information, it is likely that the volume of the blood sent into the actual sample was not sufficient.The device labeling does address the potential for such an event in the instruction for use (ifu) with statements such as the following: "the capiox hemoconcentrator is designed to operate at flow rates within the range of 100 to 500 ml/min during ultrafiltration.Do not use blood flow rates outside this range.Less than 100ml/min blood flow may cause blood coagulation in the device.Do not exceed 50% hematocrit at the blood outlet during ultrafiltration.Do not stop blood flow during extracorporeal circulation as it may cause clotting in the system.A blood flow at least 50l/min is recommended even if ultrafiltration is stopped by clamping the filtrate line." (b)(4).All available information has been placed on file in quality assurance at the manufacturing facility for appropriate tracking, trending and follow-up.
 
Event Description
The user facility reported a clog in the capiox device during a procedure.Follow up communication with the user facility confirmed the following information; hemoconcentration started immediately after the initiation of the circulation with the pressure applied only with the centrifugal pump; five minutes later, removed water did not come out of the filtrate side with the blood flow being normal; the pressure inside the circuit was increased from 300mmhg to 400mmhg; and once pressure was increased water started flowing sufficiently.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX HEMOCONCENTRATOR
Type of Device
DIALYZER
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA   418
Manufacturer Contact
jennifer suh
reg. no. 2243441
2101 cottontail ln.
somerset, NJ 08873
8002837866
MDR Report Key6471547
MDR Text Key72347023
Report Number9681834-2017-00063
Device Sequence Number1
Product Code KDI
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K973516
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial
Report Date 04/07/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2017
Device Catalogue NumberCX-XR270M024
Device Lot Number160729
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/14/2017
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 03/10/2017
Initial Date FDA Received04/07/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/29/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age60 YR
Patient Weight50
-
-